Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Denali Therapeutics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 211
- +3 vs. Q4 2023
- Shares held
- 122.4M
- +7.40M (+6.4%) vs. Q4 2023
- Total value
- $2.51B
- +$47.5M (+1.9%) vs. Q4 2023
- New holders
- 36
- 76 more added
- Sold out
- 33
- 69 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 294 | $4.00B |
| Q1 2026 | 269 | $2.82B |
| Q4 2025 | 250 | $2.50B |
| Q3 2025 | 240 | $1.97B |
| Q2 2025 | 231 | $1.93B |
| Q1 2025 | 222 | $1.85B |
| Q4 2024 | 224 | $2.61B |
| Q3 2024 | 217 | $3.69B |
| Q2 2024 | 203 | $2.88B |
| Q1 2024 | 211 | $2.51B |
| Q4 2023 | 209 | $2.47B |
| Q3 2023 | 195 | $2.24B |
| Q2 2023 | 203 | $3.18B |
| Q1 2023 | 202 | $2.49B |
| Q4 2022 | 199 | $2.94B |
| Q3 2022 | 200 | $2.84B |
| Q2 2022 | 188 | $2.73B |
| Q1 2022 | 190 | $2.79B |
| Q4 2021 | 213 | $3.80B |
| Q3 2021 | 214 | $4.28B |
| Q2 2021 | 210 | $6.32B |
| Q1 2021 | 218 | $4.60B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Denali Therapeutics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 2,759,633 | $56.6M | 0.01% | +100,337+3.8% | Added |
| Baker Bros. Advisors LP | 3,731,695 | $76.6M | 0.96% | +1,124,499+43.1% | Added |
| Takeda Pharmaceutical Co Ltd | 4,214,559 | $86.5M | 29.92% | 00.0% | Unchanged |
| Crestline Management, LP | 5,210,732 | $106.9M | 10.12% | −450,000−7.9% | Reduced |
| Temasek Holdings (Private) Ltd | 5,706,345 | $117.1M | 0.65% | −1,189,647−17.3% | Reduced |
| Capital Research Global Investors | 6,049,957 | $124.1M | 0.03% | +3,140,429+107.9% | Added |
| State Street Corp | 6,323,872 | $129.8M | 0.01% | +837,924+15.3% | Added |
| Wellington Management Group LLP | 8,269,949 | $169.7M | 0.03% | +995,232+13.7% | Added |
| Vanguard Group Inc | 10,968,293 | $225.1M | 0.00% | +133,810+1.2% | Added |
| BlackRock Inc. | 12,199,856 | $250.3M | 0.01% | +656,410+5.7% | Added |
| Baillie Gifford & Co | 14,041,228 | $288.1M | 0.22% | −219,496−1.5% | Reduced |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,351,900−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −644,406−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −461,769−100.0% | Sold out |
| Eagle Asset Management Inc | 0 | $0 | 0.00% | −315,520−100.0% | Sold out |
| Mitsubishi UFJ Trust & Banking Corp | 0 | $0 | 0.00% | −246,190−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −176,131−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −161,946−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −154,000−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −144,461−100.0% | Sold out |
| Pathway Capital Management, LP | 0 | $0 | 0.00% | −69,450−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −65,105−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −60,304−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −44,292−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −27,429−100.0% | Sold out |
| VELA Investment Management, LLC | 0 | $0 | 0.00% | −26,145−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −24,318−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −18,327−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −16,728−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,576−100.0% | Sold out |
| Arthur M. Cohen & Associates, LLC | 0 | $0 | 0.00% | −10,564−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −9,965−100.0% | Sold out |
| Brandywine Managers, LLC | 0 | $0 | 0.00% | −9,601−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −8,300−100.0% | Sold out |
| Tao Capital Management LP | 0 | $0 | 0.00% | −3,042−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −309−100.0% | Sold out |
| Morton Brown Family Wealth, LLC | 0 | $0 | 0.00% | −298−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Institutional & Family Asset Management, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Bartlett & Co. LLC | – | – | – | – | Not filed |